Bacteriocins of Clostridium perfringens. 1. Isolation and preliminary studies.
D000327:Adsorption; D000362:Agar; D000992:Antitoxins / Q000494:pharmacology; D001430:Bacteriocins / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D001431:Bacteriological Techniques; D001769:Blood; D003016:Clostridium perfringens / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism / Q000528:radiation effects; D003470:Culture Media; D004352:Drug Resistance, Microbial; D006358:Hot Temperature; D008826:Microbial Sensitivity Tests; D008854:Microscopy, Electron; D013045:Species Specificity; D013053:Spectrophotometry; D013997:Time Factors; D014357:Trypsin / Q000494:pharmacology; D014466:Ultraviolet Rays
D000992:Antitoxins; D001430:Bacteriocins; D003470:Culture Media; D000362:Agar; D014357:Trypsin